April 21, 2005 NASD OTC-BB: MRDAF

Meridian to Attend the 49th Northwest Naturopathic Convention
Fairmont Hotel - Vancouver, Canada – April 22- 24, 2005

Meridian Co., Ltd. ("Meridian") (OTC BB: MRDAF), is pleased to announce that it will be attending the Northwest Naturopathic Convention, being held at the Fairmont Hotel in Vancouver, British Columbia, Canada. The event will take place between Friday, April 22 and Sunday, April 24, 2005.
This is the longest existing annual convention in the history of naturopathic medicine in the world! This convention provides a unique opportunity to enhance regional strategic relationships that will provide exposure for Meridian’s products. One of the most important aspects of the Northwest tradition has been the value of sharing knowledge as well as improving the profession’s cohesion.
This convention will serve as a vehicle that unifies the traditional practices of naturopathic medicine with the advancing knowledge of the 21st century. Meridian is excited to have the opportunity to present its preventative medical technology to this progressive audience.
Meridian will be demonstrating the Digital Pulse Analyzer (“DPA”) and expects the attendees to be very receptive to the easy to use, FDA approved cardiovascular diagnostic device. The DPA is a perfect fit in a naturopathic environment and has been proven to increase supplement sales by proving the efficacy of treatment options.

More About: Digital Pulse Analyzer (“DPA”)

The “DPA” accurately measures the elasticity of small and large arteries and provides health care practitioners with critical information regarding arterial aging. This FDA approved device is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions.

The Company feels that use of the “DPA” can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention, and ultimately assist to decrease the associated financial costs placed on the health care industry. Cardiovascular disease is the #1 killer in the United States with an estimated economic cost of approximately US$298 billion.

ABOUT MERIDIAN

Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of its products.

Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity.

For further product information please contact:
Belgium Medical Inc. - North American Distribution Office
Debbie Williams, President
1-877-738-8119